Mono Pharmacare Complete Financial Statements
MONOPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023
Complete Financial Data Export
Export complete financial statements for Mono Pharmacare (MONOPHARMA).
Downloads include all available records across all periods.
For market performance, see the
MONOPHARMA stock price today
.
Profitability Ratios
Net Profit Margin
1.78%
2025 data
EBITDA Margin
5.33%
2025 data
Operating Margin
5.00%
2025 data
Return on Assets
2.73%
2025 data
Return on Equity
9.68%
2025 data
Balance Sheet Ratios
Current Ratio
4.19
2025 data
Debt to Equity
3.55
2025 data
Equity Ratio
28.18%
2025 data
Asset Turnover
1.54
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+35.8%
Year-over-Year
Equity Growth
+10.7%
Year-over-Year
Liabilities Growth
+35.8%
Year-over-Year
Operating Cash Flow Growth
+55.6%
Year-over-Year
Financing Cash Flow Growth
-37.5%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 |
|---|---|---|---|---|
| Revenue | 0 | 169 | 122 | 27 |
| Expenses | 0 | 161 | 116 | 26 |
| EBITDA | 0 | 9 | 6 | 2 |
| Operating Profit Margin % | 0.00% | 5.00% | 5.00% | 6.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 4 | 3 | 1 |
| Profit Before Tax | 0 | 5 | 3 | 1 |
| Tax | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 3 | 3 | 1 |
| Earnings Per Share (₹) | 0.00 | 1.75 | 1.59 | 0.71 |
Related Pages for Mono Pharmacare
Additional stock information and data for MONOPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 |
|---|---|---|---|
| ASSETS | |||
| Total Assets | 110 | 81 | 63 |
| Current Assets | 109 | 80 | 61 |
| Fixed Assets | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 109 | 80 | 62 |
| LIABILITIES | |||
| Total Liabilities | 110 | 81 | 63 |
| Current Liabilities | 26 | 17 | 18 |
| Non-Current Liabilities | |||
| SHAREHOLDERS' EQUITY | |||
| Total Equity | 31 | 28 | 13 |
| Share Capital | 18 | 18 | 12 |
| Reserves & Surplus | 14 | 10 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 |
|---|---|---|---|
| Operating Activities | -4 | -9 | -28 |
| Investing Activities | 0 | 0 | -1 |
| Financing Activities | 5 | 8 | 30 |
| Net Cash Flow | 0 | 0 | 0 |